Your ANSwer for Workers' Compensation Medical Cost Containment

Call Us Today!|info@ans-solutions.com

Can Technology Help?

State and local governments collect a lot of health data, but as it turns out, there are many roadblocks to putting that data to its highest and best use. Building a bridge, however, could create the potential for its use in battling the U.S. opioid epidemic, which is taking its toll in every corner of the country, across all ages and socioeconomic backgrounds. Just how could digging a little deeper into this data help to uncover the hidden facets of this epidemic?

Mining for Gold

Law enforcement, […]

August 11th, 2017|Workers Compensation Industry|Comments Off on Can Technology Help?
  • drug utilization
    Permalink Gallery

    Government Struggles to Hold Opioid Manufacturers Accountable

Government Struggles to Hold Opioid Manufacturers Accountable

For the first time ever, the U.S. DEA targeted a prescription drug manufacturer for their role in black market opioids and damages incurred. Mallinckrodt Pharmaceuticals, one of the largest national manufacturers of the highly addictive generic painkiller oxycodone, one of the leading drugs responsible for the more than 15,000 overdose deaths in 2015, was accused of shirking its responsibility to report suspicious drug orders.

Who’s to Blame For The Opioid Epidemic?

Created at Mallinckrodt’s Hobart, NY facility, oxycodone shipped via its distributor network, including KeySource, Sunrise Wholesale and Cardinal […]

July 24th, 2017|Clinical Alert, Drug Utilization Review, Pharmaceutical Industry|Comments Off on Government Struggles to Hold Opioid Manufacturers Accountable
  • opioid showdown
    Permalink Gallery

    Opioid Showdown: Can States Surpass Federal & Address Big Pharma?

Opioid Showdown: Can States Surpass Federal & Address Big Pharma?

With some states and areas across the country on the receiving end of opioid painkiller prescription shipments that outnumber the people housed therein, state officials are beginning to address the link between the opioid crisis, Big Pharma, and the heavy burden weighing on their municipalities. In an attempt to hold Big Pharma accountable, they’re taking a page out of past lawsuits against tobacco companies – and suing them.

Key Players
Until now, these multibillion dollar companies have been sidelined in the fight against the opioid epidemic. Now they’re being looked at […]

July 10th, 2017|Pharmacotherapy Review|Comments Off on Opioid Showdown: Can States Surpass Federal & Address Big Pharma?

How Does Doctor Shopping Impact The Opioid Epidemic?

Surprisingly, the non-medical prescription of drugs, including opioids, continues, with only states holding legislation against this dubious practice smothering the flames helping stoke the opioid addiction fire. Since 1999, deaths from prescription opioids have quadrupled, alongside opioid sales of painkillers such as oxycodone (Oxycontin) and hydrocodone (Vicodin). But this hasn’t stopped opioid abusing patients from trying to nab a couple of extra pills by ‘doctor shopping,’ the practice of hopping from physician to physician and playing the numbers until finding a doctor who will meet the patient’s desire for […]

June 26th, 2017|Drug Utilization Review|Comments Off on How Does Doctor Shopping Impact The Opioid Epidemic?

Medical Marijuana Vs. Big Pharma

Increasingly gaining ground as an accepted medicine by top health associations, researchers, and medical journals, the marijuana industry continues its massive expansion, with legalization encompassing more than half the U.S. Predicted to expand nationwide by 2021 by investment firm The Motley Fool, other sectors of the economy are feeling the strain of the industry’s new growth – but no one greater than Big Pharma.

Marijuana & Pharmaceutical Market Share
In an effort to determine how cannabis cash flow is effecting the pharmaceutical industry, researchers at the University of Georgia uncovered just […]

June 14th, 2017|Drug Utilization Review, Pharmaceutical Industry|Comments Off on Medical Marijuana Vs. Big Pharma

Medical Marijuana and the Workers Compensation Conundrum

Because the U.S. Federal Government has dug-in its feet, leaving marijuana as an illegal, Schedule I drug under the Controlled Substances Act, state governments have been left to individually pave their own legalization paths, leaving a frustrated public in the wake. Employers, employees, doctors, workers comp case managers, and more feel frustratingly in-the-dark as ever-diversified, continually evolving legislation continues to change the landscape. This is the first post of our two part series of spotlighting medical marijuana in the marketplace.

What We Do Know About Medical Marijuana

May 31st, 2017|Drug Utilization Review, Medical Cost Containment|Comments Off on Medical Marijuana and the Workers Compensation Conundrum
  • opioid abuse treatment
    Permalink Gallery

    Are Primary Care Physicians Leaving Opioid Deaths to Chance?

Are Primary Care Physicians Leaving Opioid Deaths to Chance?

A recently released study from the Journal of Addiction Medicine has uncovered an alarming trend. Patients with opioid addiction, also referred to as opioid use disorder (OUD), experience an alarmingly high death rate – one 10 times higher than those not suffering opioid addiction. Not surprisingly, the study has raised some tough questions about the existing treatment infrastructure, and the system’s failure to identify and aid such at-risk individuals.

The Sobering Stats

Using electronic health records from a major university healthcare system from more than 2,500 patients ranging in age from […]

May 8th, 2017|Pharmacotherapy Review|Comments Off on Are Primary Care Physicians Leaving Opioid Deaths to Chance?
  • workers compensation industry technology
    Permalink Gallery

    How Technology Is Shaping The Workers’ Compensation Industry

How Technology Is Shaping The Workers’ Compensation Industry

The technology now used within today’s workers’ comp industry is remarkable compared to what was available just a few decades prior. A dominant component of advocacy, claims, and treatment, technology is helping employers and insurers work the bugs out of the process, producing amazing results and the promise of even more unbelievable advancements on the horizon…

How is Technology Reshaping the Workers’ Compensation Industry?

  • Paper Falls by the Wayside
    • NOW: Endless forms and lost paperwork are no longer, replaced by automated forms, electronic signatures and correspondence that is both faster and easily […]
April 10th, 2017|Drug Utilization Review, Medical Cost Projection, Pharmacotherapy Review|Comments Off on How Technology Is Shaping The Workers’ Compensation Industry

The ER and Opioids

A common thread has been found in opioid addiction, winding its way from the ER and into homes across the nation. Beginning as a single prescription for a minor issue or unexpected injury, ER physicians are inadvertently rolling the dice and chancing long-term addiction in their quest to simply relieve pain, when there could be better alternatives.

How Commonly are Opioids Tossed-Out in the ER?

Medical researchers studied hundreds of thousands of Medicare-paid ER admissions nationwide, and uncovered a surprising trend in standard approaches to treating […]

March 27th, 2017|Pharmacotherapy Review|Comments Off on The ER and Opioids

The Position of Workers’ Compensation in 2017

With the election of a new president who is ushering in a new era for the government, the trickle-down effect to the workers’ compensation industry just might sweep you off your feet. Prepare yourself with the industry knowledge you need, and avoid being overtaken by the tsunami…

The 2017 Workers’ Compensation Industry Issues to Watch:

  • The Affordable Care Act (ACA)
    Like a rogue wave, changes to the ACA may pop-up with little notice. These changes will influence the industry, including claims frequency, claims shifting, and cost shifting if/when private insurance is lost […]

March 13th, 2017|Workers Compensation Industry, Workers Compensation Payers|Comments Off on The Position of Workers’ Compensation in 2017